Diagnostic utility of isolated tube C positivity in T-cell receptor β testing using BioMED-2 primers

5Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: T-cell receptor (TCR) gene rearrangement studies are widely used for assessing T-cell clonality. The frequency and significance of clonal peaks restricted to TCR β (TCRB) tube C are uncertain. We retrospectively reviewed 80 TCR studies performed on bone marrow/ peripheral blood. Methods: TCRB and TCR γ (TCRG) analyses were performed using BIOMED-2 primers. A peak was considered clonal or atypical if it was reproducible and 5× or more or 3× to 5× polyclonal background, respectively. Results: TCRB analysis demonstrated 12 (15%) of 80 cases with one to four isolated peaks in tube C (>3×) with polyclonal pattern in tubes A and B. TCRG analysis was monoclonal in two cases (both definite T-cell neoplasms), polyclonal in four, and oligoclonal in six. Of the 10 cases without clone in TCRG, six had autoimmune disorder and none had T-cell neoplasm. Conclusions: Peaks restricted to TCRB tube C in the TCR analysis may be misleading, as it is often not indicative of an overt T-cell neoplasm.

Cite

CITATION STYLE

APA

Qayyum, S., Bullock, G. C., Swerdlow, S. H., Brower, R., Nikiforova, M., & Aggarwal, N. (2019). Diagnostic utility of isolated tube C positivity in T-cell receptor β testing using BioMED-2 primers. American Journal of Clinical Pathology, 151(4), 386–394. https://doi.org/10.1093/AJCP/AQY157

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free